AU2023213780B2 — Crystal form and salt of phenothiazine compound, preparation method therefor and use thereof
Assigned to Chengdu Henghao Innovative Science And Technology Co Ltd · Expires 2025-11-13 · 1y expired
What this patent protects
Provided are a crystal form and salt of a phenothiazine compound, a preparation method therefor and a use thereof. A hydrochloride of the phenothiazine compound and a crystal thereof can be used as ferroptosis inhibitors, and the hydrochloride and the crystal thereof have relativ…
USPTO Abstract
Provided are a crystal form and salt of a phenothiazine compound, a preparation method therefor and a use thereof. A hydrochloride of the phenothiazine compound and a crystal thereof can be used as ferroptosis inhibitors, and the hydrochloride and the crystal thereof have relatively good solubility, stability, oral absorption bioavailability, and druggability.
Drugs covered by this patent
- Jesduvroq (DAPRODUSTAT) · GSK
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.